Viewing Study NCT02448420


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-01-29 @ 3:15 AM
Study NCT ID: NCT02448420
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2015-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
Sponsor: SOLTI Breast Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module